Ftse Mib
33.986,90
1,06%
DAX
18.175,21
1,01%
S&P 500
5.180,74
1,03%
NASDAQ
16.349,25
1,19%
Bitcoin
63.674,53
0,80%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSXV Biosyent Inc (RX) Biosyent Inc (RX) Notizie

Biosyent Inc

RX
8,51
-0,14 (-1,62%)
06 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: TSX Venture
Tipo: Azione
Valuta: CAD

Ultime notizie

Data Ora Fonte Titolo
23/4/202423:45GLOBEBioSyent to Attend Planet MicroCap Showcase
15/4/202422:31GLOBEBioSyent Announces Extension of RepaGyn® and Proktis-M®..
03/4/202414:00GLOBEFeraMAX® Named #1 Recommended Iron Supplement in Canada by..
01/4/202420:00GLOBEBioSyent to Present at LD Micro New York Investor Conference
27/3/202423:34GLOBEBioSyent Announces Grant of Restricted Share Units
13/3/202422:30GLOBEBioSyent Releases Financial Results for Fourth Quarter and..
06/3/202422:30GLOBEBioSyent Schedules Fourth Quarter and Full Year 2023..
21/2/202414:00GLOBEBioSyent Named to 2024 TSX Venture 50
06/2/202422:30GLOBEBioSyent Declares First Quarter 2024 Dividend
13/12/202314:00GLOBEBioSyent Announces Renewal of Normal Course Issuer Bid
20/11/202314:30GLOBEBioSyent Announces the Availability of Gelclair® in Canada
16/11/202314:00GLOBEBioSyent Releases Q3 and YTD 2023 Financial Results
15/11/202322:34GLOBEBioSyent Declares Fourth Quarter 2023 Dividend
09/11/202314:00GLOBEBioSyent Schedules Q3 and YTD 2023 Earnings Release for..
18/10/202314:00GLOBEBioSyent Launches "menopauseinformation.ca" on World..
24/8/202302:22PRNCATSX Venture Exchange Stock Maintenance Bulletins
22/8/202322:15GLOBEBioSyent Releases Q2 and H1 2023 Financial Results
22/8/202322:01GLOBEBioSyent Declares Third Quarter 2023 Dividend
15/8/202322:30GLOBEBioSyent Schedules Q2 and H1 2023 Earnings Release for..
08/8/202314:00GLOBEBioSyent Launches Inofolic® for Women with Polycystic Ovary..
06/7/202323:53GLOBEBioSyent Pharma to Introduce Gelclair® at AHNS 11th..
20/6/202314:30GLOBEBioSyent Announces Long-term Extension of Cathejell®..
31/5/202323:42GLOBEBioSyent Announces Approval of New Product
26/5/202314:00GLOBEBioSyent Releases Financial Results for Q1 2023
25/5/202323:40GLOBEBioSyent Declares Second Quarter 2023 Dividend
18/5/202314:30GLOBEBioSyent Schedules Q1 2023 Earnings Release for May 26, 2023
Apertura: 8,60 Min: 8,51 Max: 8,61
Chiusura: 8,65

La tua Cronologia

TSXV
RX
Biosyent
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network